Taxane Chemotherapy and Nail Toxicity in Women With Breast Cancer; Stage Two: Evaluation of Interventions
Breast Cancer, Nail Toxicity
About this trial
This is an interventional treatment trial for Breast Cancer
Eligibility Criteria
Inclusion Criteria:
- women over the age of 18 years who have been diagnosed with a breast cancer.
- must be receiving adjuvant or neo-adjuvant Taxotere chemotherapy for breast cancer.
- participants must be fluent English speakers to be eligible to take part, as there are no resources or additional funding for translators or interpreting services.
- Participants must provide informed consent.
Exclusion Criteria:
- Male patients with a diagnosis of breast cancer
- Patients who are non-fluent English speakers
- Patients with a known hypersensitivity reaction to nail/ relevant cosmetic products
- Previous treatment with taxane chemotherapy with the last two years
- Patients with only one upper limb.
- Patients with a neurological deficit to the upper limb (eg, stroke affecting one side)
Sites / Locations
- Beatson Oncology Centre
Arms of the Study
Arm 1
Arm 2
Arm 3
No Intervention
Experimental
Experimental
Control - standard care
Intervention - Oncolife drops
Intervention - Nail polish
Participants will receive standard care regarding nail toxicity. This entails advice to keep nails trim and the provision of a nail oil to massage into the nail daily. Participants will also receive advice in relation to general healthy living.
Participants will receive the same standard care as the control arm, except for the nail drops. The participants will also receive Onicolife nail drops to be applied twice daily.
Participants will receive the same standard care as the control arm, except for the nail drops. The participants will also receive a dark coloured nail polish to be applied as instructed.